Peptide CDMO Market, Global Outlook and Forecast 2022-2028

 Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-peptide-cdmo-forecast-2022-2028-154

This report contains market size and forecasts of Peptide CDMO in global, including the following market information:

  • Global Peptide CDMO Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global Peptide CDMO Market Sales, 2017-2022, 2023-2028, (Tons)

The global Peptide CDMO market was valued at 2369.8 million in 2021 and is projected to reach US$ 6106.7 million by 2028, at a CAGR of 14.5% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

APIs and Intermediates Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Peptide CDMO include Bachem, PolyPeptide, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript and Xinbang Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide CDMO manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Peptide CDMO Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Peptide CDMO Market Segment Percentages, by Type, 2021 (%)

  • APIs and Intermediates
  • FDF

Global Peptide CDMO Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Peptide CDMO Market Segment Percentages, by Application, 2021 (%)

  • Commercial
  • Academic Research

Global Peptide CDMO Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Peptide CDMO Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Peptide CDMO revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Peptide CDMO revenues share in global market, 2021 (%)
  • Key companies Peptide CDMO sales in global market, 2017-2022 (Estimated), (Tons)
  • Key companies Peptide CDMO sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Bachem
  • PolyPeptide
  • AmbioPharm
  • USV Peptides
  • Thermo Fisher
  • Bio Basic
  • JPT
  • Genscript
  • Xinbang Pharma
  • ScinoPharm
  • SN Biopharm
  • CBL
  • Piramal Pharma
  • CordenPharma
  • CPC Scientific
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Location: Germany

Comments

Post a Comment

Popular posts from this blog

Global L7e Quadricycles Market Research Report 2024(Status and Outlook)

Image
  Industry Overview The "Global L7e Quadricycles Market" was valued at US$ 700.07 Million in 2024 and is projected to reach US$ 896.08 Million by 2030, at a CAGR of 4.20% during the forecast period. Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7894099/global-le-quadricycles-2024-31 The global L7e quadricycles market is witnessing significant growth, driven by increasing urbanization, rising demand for efficient and eco-friendly transportation solutions, and advancements in automotive technology. L7e quadricycles, also known as light quadricycles, are lightweight vehicles that offer a balance between functionality and compactness, making them ideal for urban commuting and short-distance travel. These vehicles typically have lower emissions and better fuel efficiency compared to traditional cars, aligning with global sustainability goals and stricter environmental regulations. Key players in the market are focusing on electric v...
Read more

Europe Travel eSIM Market Outlook and Forecast 2024-2030

  The Europe Travel eSIM Market was valued at US$ 50.8 million in 2023 and is projected to reach US$ 318.3 million by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 28.9% during the forecast period (2023-2030). Report Includes Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7996446/europe-travel-esim-2024-2030-517 This report is an essential reference for who looks for detailed information on Europe Travel eSIM . The report covers data on Europe markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Europe major vendors¡¯ information. In addition to the data part, the report also provides overview of Travel eSIM , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available. This report aims to provide a comprehen...
Read more

Insurance Franchise Market

  Insurance Franchise market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Insurance Franchise market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030. Segment by Type Office Agency Retail Agency Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at  https://www.24marketreports.com/report-sample/global-insurance-franchise-2023-326 Segment by Application Individual Enterprise By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest ...
Read more